Literature DB >> 27699881

Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.

Yoshitaka Hiruma1, Andre Koch2, Shreya Dharadhar1, Robbie P Joosten1, Anastassis Perrakis1.   

Abstract

Monopolar spindle 1 (Mps1, also known as TTK) is a protein kinase crucial for ensuring that cell division progresses to anaphase only after all chromosomes are connected to spindle microtubules. Incomplete chromosomal attachment leads to abnormal chromosome counts in the daughter cells (aneuploidy), a condition common in many solid cancers. Therefore Mps1 is an established target in cancer therapy. Mps1 kinase inhibitors include reversine (2-(4-morpholinoanilino)-6-cyclohexylaminopurine), a promiscuous compound first recognized as an inhibitor of the Aurora B mitotic kinase. Here, we present the 3.0-Å resolution crystal structure of the Mps1 kinase domain bound to reversine. Structural comparison of reversine bound to Mps1 and Aurora B, indicates a similar binding pose for the purine moiety of reversine making three conserved hydrogen bonds to the protein main chain, explaining the observed promiscuity of this inhibitor. The cyclohexyl and morpholinoaniline moieties of reversine however, have more extensive contacts with the protein in Mps1 than in Aurora B. This is reflected both in structure-based docking energy calculations, and in new experimental data we present here, that both confirm that the affinity of reversine towards Mps1 is about two orders of magnitude higher than towards Aurora B. Thus, our data provides detailed structural understanding of the existing literature that argues reversine inhibits Mps1 more efficiently than Aurora B based on biochemical and in-cell assays. Proteins 2016; 84:1761-1766.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  2-(4-morpholinoanilino)-6-cyclohexylaminopurine; X-ray crystallography; microscale thermophoresis; mitotic kinase; reversine

Mesh:

Substances:

Year:  2016        PMID: 27699881     DOI: 10.1002/prot.25174

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  10 in total

1.  Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.

Authors:  Yoshitaka Hiruma; Andre Koch; Nazila Hazraty; Foteini Tsakou; René H Medema; Robbie P Joosten; Anastassis Perrakis
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

2.  Haspin inhibition reveals functional differences of interchromatid axis-localized AURKB and AURKC.

Authors:  Suzanne M Quartuccio; Shweta S Dipali; Karen Schindler
Journal:  Mol Biol Cell       Date:  2017-06-28       Impact factor: 4.138

3.  Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents.

Authors:  Nora M Gerhards; Vincent A Blomen; Merve Mutlu; Joppe Nieuwenhuis; Denise Howald; Charlotte Guyader; Jos Jonkers; Thijn R Brummelkamp; Sven Rottenberg
Journal:  Mol Oncol       Date:  2018-05-01       Impact factor: 6.603

4.  Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma.

Authors:  Sonia Simon Serrano; Wondossen Sime; Yasmin Abassi; Renée Daams; Ramin Massoumi; Mohamed Jemaà
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

5.  Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.

Authors:  Yuan Chen; Wenquan Yu; Cui-Cui Jiang; Jin-Gui Zheng
Journal:  Molecules       Date:  2018-06-20       Impact factor: 4.411

6.  Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells.

Authors:  Piya Prajumwongs; Orawan Waenphimai; Kulthida Vaeteewoottacharn; Sopit Wongkham; Kanlayanee Sawanyawisuth
Journal:  PeerJ       Date:  2021-01-07       Impact factor: 2.984

7.  Targeting glioma cells by antineoplastic activity of reversine.

Authors:  Camila Hirakata; Keli Lima; Bruna Oliveira De Almeida; Lívia Bassani Lins De Miranda; Katharine Gurgel Dias Florêncio; Luciana Costa Furtado; Leticia Veras Costa-Lotufo; João Agostinho Machado-Neto
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

8.  3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug Discovery.

Authors:  Albert J Kooistra; Márton Vass; Ross McGuire; Rob Leurs; Iwan J P de Esch; Gert Vriend; Stefan Verhoeven; Chris de Graaf
Journal:  ChemMedChem       Date:  2018-02-14       Impact factor: 3.466

9.  Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1.

Authors:  Mohamed Jemaà; Yasmin Abassi; Chamseddine Kifagi; Myriam Fezai; Renée Daams; Florian Lang; Ramin Massoumi
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

10.  Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer Cells.

Authors:  Bartolomeo Bosco; Andrea Defant; Andrea Messina; Tania Incitti; Denise Sighel; Angela Bozza; Yari Ciribilli; Alberto Inga; Simona Casarosa; Ines Mancini
Journal:  Molecules       Date:  2018-08-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.